Orlando Health ended the 2023 fiscal year with an 8.1% operating margin, one of the highest among health systems in the US. Here are 10 things to know about the nonprofit health system.
Arrivo BioVentures, which emerged from stealth mode less than two years ago with $49 million in funding and four drug candidates, has raised another $45 million and plans to advance its treatment focused on major depression disorder or MDD.
Durham-based 410 Medical, a medical device company developing new technologies for emergency and critical care, has completed its $7.5 million Series B venture capital financing. Here are the details.